Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-18
1994-03-08
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514448, 549 59, 549 60, 549 71, 5483151, A01N 4308, A61K 3138, C07D40912, C07D23354
Patent
active
052927679
ABSTRACT:
A compound of the formula [I] and pharmaceutically acceptable salts thereof; and a synthetic intermediate represented by the formula [II] and pharmaceutically acceptable salts thereof, ##STR1## wherein R 1 is hydrogen or lower alkyl;
REFERENCES:
Chemical Abstracts, vol. 109, No. 17, Oct. 24, 1988, Columbus, OH. US; Abstract No. 149494r, Inoue, Yoshihiko and Al `A wittig type arrangement of 2-methoxycarbonyl-2-phenyl-1,3-dithane and 2,2-diphenyl-1,3-dithiepane`, p. 733; column R; of Bull. Inst. Chem. Res. Kyoto Univ., vol. 65, No. 3, 1987, pp. 121-124.
Bach et al., Thymulin, A Zinc-Dependent Hormone, Med. Oncol. & Tumor Pharmacother, vol. 6, No. 1, pp. 25-29, 1989, Great Britain.
Kato Nobuharu
Kawashima Yoichi
Mita Shiro
Morishita Masataka
Suhara Hiroshi
Lambkin Deborah
Robinson Allen J.
Santen Pharmaceutical Co. Ltd.
LandOfFree
Tetrahydrothiophene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrothiophene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrothiophene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-153758